fondaparinuxhttp://www.unboundmedicine.com/medline/ebm/research/fondaparinuxUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis.http://www.unboundmedicine.com/medline/ebm/record/19890611/full_citation/Extended_prophylaxis_of_venous_thromboembolism_with_fondaparinux_in_patients_undergoing_major_orthopaedic_surgery_in_Italy:_a_cost_effectiveness_analysis_Capri S, Ageno W, Imberti D, et al. 
Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis. [JOURNAL ARTICLE]
Intern Emerg Med 2009 Nov 5.
Abstract | Full Citation | Find Related Articles Heptest-STAT, a new assay for monitoring of low-molecular-weight heparins, is not influenced by pregnancy-related changes of blood plasma.http://www.unboundmedicine.com/medline/ebm/record/19888540/full_citation/Heptest_STAT_a_new_assay_for_monitoring_of_low_molecular_weight_heparins_is_not_influenced_by_pregnancy_related_changes_of_blood_plasma_Dempfle CE, Zharkowa U, Elmas E, et al. 
Heptest-STAT, a new assay for monitoring of low-molecular-weight heparins, is not influenced by pregnancy-related changes of blood plasma. [Journal Article]
Thromb Haemost 2009 Nov; 102(5):1001-6.
Abstract | Full Citation | Find Related Articles Binding between heparin and the integrin VLA-4.http://www.unboundmedicine.com/medline/ebm/record/19888514/full_citation/Binding_between_heparin_and_the_integrin_VLA_4_Schlesinger M, Simonis D, Schmitz P, et al. 
Binding between heparin and the integrin VLA-4. [Journal Article]
Thromb Haemost 2009 Nov; 102(5):816-22.
Abstract | Full Citation | Find Related Articles Development of idraparinux and idrabiotaparinux for anticoagulant therapy.http://www.unboundmedicine.com/medline/ebm/record/19888513/full_citation/Development_of_idraparinux_and_idrabiotaparinux_for_anticoagulant_therapy_Harenberg J 
Development of idraparinux and idrabiotaparinux for anticoagulant therapy. [Journal Article]
Thromb Haemost 2009 Nov; 102(5):811-5.
Abstract | Full CitationFrom heparin to EP217609: The long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile.http://www.unboundmedicine.com/medline/ebm/record/19888512/full_citation/From_heparin_to_EP217609:_The_long_way_to_a_new_pentasaccharide_based_neutralisable_anticoagulant_with_an_unprecedented_pharmacological_profile_Petitou M, Nancy-Portebois V, Dubreucq G, et al. 
From heparin to EP217609: The long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile. [Journal Article]
Thromb Haemost 2009 Nov; 102(5):804-10.
Abstract | Full Citation | Find Related Articles Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials.http://www.unboundmedicine.com/medline/ebm/record/19884469/full_citation/Major_Bleeding_Mortality_and_Efficacy_of_Fondaparinux_in_Venous_Thromboembolism_Prevention_Trials_Eikelboom JW, Quinlan DJ, O'Donnell M 
Major Bleeding, Mortality, and Efficacy of Fondaparinux in Venous Thromboembolism Prevention Trials. [JOURNAL ARTICLE]
Circulation 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Update on heparin: what do we need to know?http://www.unboundmedicine.com/medline/ebm/record/19882363/full_citation/Update_on_heparin:_what_do_we_need_to_knowWeitz DS, Weitz JI 
Update on heparin: what do we need to know? [JOURNAL ARTICLE]
J Thromb Thrombolysis 2009 Nov 2.
Abstract | Full Citation | Find Related Articles Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.http://www.unboundmedicine.com/medline/ebm/record/19854398/full_citation/Fondaparinux_for_prevention_of_venous_thromboembolism_in_high_risk_trauma_patients:_a_pilot_study_Lu JP, Knudson MM, Bir N, et al. 
Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study. [Journal Article]
J Am Coll Surg 2009 Nov; 209(5):589-94.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Favorable coagulation profile with fondaparinux after hip surgery in elderly patients.http://www.unboundmedicine.com/medline/ebm/record/19838769/full_citation/Favorable_coagulation_profile_with_fondaparinux_after_hip_surgery_in_elderly_patients_Kudrnová Z, Kvasnička J, Kudrna K, et al. 
Favorable coagulation profile with fondaparinux after hip surgery in elderly patients. [JOURNAL ARTICLE]
Int J Hematol 2009 Oct 17.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: Successful intervention with eculizumab and fondaparinux.http://www.unboundmedicine.com/medline/ebm/record/19836075/full_citation/Paroxysmal_nocturnal_hemoglobinuria_following_alemtuzumab_immunosuppressive_therapy_for_myelodysplastic_syndrome_and_complicated_by_recurrent_life_threatening_thrombosis_despite_anticoagulation:_Successful_intervention_with_eculizumab_and_fondaparinux_Cheng KL, Brody J, Warshall CE, et al. 
Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: Successful intervention with eculizumab and fondaparinux. [LETTER]
Leuk Res 2009 Oct 14.
Full Citation | Find Related Articles